Skip to main content
. 2021 Jul 1;8(7):ofab298. doi: 10.1093/ofid/ofab298

Table 3.

Outcome of MSSA Versus MRSA PJI Treated With DAIR

Study N Studiesa N Patients Pooled Success Rateb
MSSA PJI 28 1381 60%
MRSA PJI 26 416 58%
Hip MSSA PJI 2 32 81%
Hip MRSA PJI 1 12 92%
Knee MSSA PJI 3 56 66%
Knee MRSA PJI 3 78 64%

Abbreviations: DAIR, debridement, antibiotics, and retention of the implant; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; PJI, prosthetic joint infection.

aPer category, studies were included if they reported specific or combined outcome for hip and/or knee MSSA and MRSA.

bBased on individual patient data.